Device Trial Radar · NCT02476851
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
Last checked: Nov 20, 2026Latest source record: Apr 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Jun 2015
Primary completion
Jul 2015
Study completion Sep 2015
Sponsor
- Lead sponsor
- Haemonetics CorporationPublic (HAE)
- Sponsor type
- Industry
- First posted
- Jun 19, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study evaluates whether whole blood transferred through the new POLFA needle assembly meets supernatant hemoglobin acceptability standards.
Conditions
- Transmission, Blood, Recipient/Donor
Interventions
POLFA (Needle Assembly)Device
Each subject receives the same intervention and blood is drawn into both the INA and CNA. The difference is the order in which the CNA or INA is applied.
Kawasumi (Needle Assembly)Device
Each subject receives the same intervention and blood is drawn into both the INA and CNA. The difference is the order in which the CNA or INA is applied.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma Supernatant HemoglobinTime frame: Following a one-time whole blood donation, samples were measured within 1 month of donation.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Haemonetics
Braintree, Massachusetts
Hoxworth Blood Center
Cincinnati, Ohio
American Red Cross Mid-Atlantic Region Blood Services
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.